Larimar Therapeutics
LRMR • NASDAQ • Stock Fundamentals
Larimar Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carole S. Ben-Maimon, with a market cap of $360.5M.
Market Cap$360.5M
Employees42.0
CEOCarole S. Ben-Maimon
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
LRM
Larimar Therapeutics FAQ
Common questions about Larimar Therapeutics
Larimar Therapeutics (LRMR) has a market capitalization of $360.5M and trades on NASDAQ.
Larimar Therapeutics has approximately 42 employees.